Table 1.
Type of vaccine | Name | Antigen | Formulation | Disease | Administration | Approved time | Approved |
---|---|---|---|---|---|---|---|
Live attenuated122 | OPV (b/m/tOPv) | Poliovirus | Aqueous | Poliomyelitis123 | Oral | 1961 | FDA |
Subunit vaccine | Dukoral® | Vibrio cholerae124 rCTB | Aqueous | Cholera | Oral | 2003 | Canada |
Live attenuated | Fluenz™/FluMist®125 | lnfluenza A and influenza B viruses | Spray | Influenza | Nasal | 2003 | FDA |
Live reassortant126 | RotaTeq® | Rotavirus | Aqueous | Infant diarrhea | Oral | 2006 | FDA |
Live attenuated | Rotarix | RIX4414 strain127 | Aqueous | Infant diarrhea | Oral | 2008 | FDA |
Inactivated | Euvichol128 Shanchol |
Vibrio cholerae | Aqueous | Cholera | Oral | 2013 | WHO |
Live attenuated | Vivotif®129 | Salmonella typhimurium | Capsule | Acute gastroenteritis | Oral | 2013 | FDA |
Adenovirus vector vaccine130 | Adenovirus Type 4 and Type 7 Vaccine | Adenovirus Type 4 and Type 7 | / | Febrile acute respiratory disease | Oral | 2011 | FDA |
Live attenuated | Vaxchora™ | Vibrio cholerae131 | Aqueous | Cholera | Oral | 2015 | FDA |